1.	Total Thyroidectomy With Harmonic Scalpel® Phase: Phase IV Type: Health services research, Treatment Status: Approved-not yet active Age: Over 18 Sponsor: Other Protocol IDs: CP005, NCT00385983
2.	p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage Phase: Phase IV Type: Treatment Status: Active Age: 18 to 85 Sponsor: Pharmaceutical / Industry Protocol IDs: rAd-p53-001, NCT00894153
3.	rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors Phase: Phase IV Type: Treatment Status: Active Age: 18 to 85 Sponsor: Pharmaceutical / Industry Protocol IDs: rAd-p53-003, NCT00902122
4.	rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors Phase: Phase IV Type: Treatment Status: Active Age: 18 to 85 Sponsor: Pharmaceutical / Industry Protocol IDs: rAd-p53-002, NCT00902083
5.	Stereotactic Body Radiotherapy for Head and Neck Tumors Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-046, NCT01344356
6.	Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: NL38127, NCT01491711
7.	Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UniHD-2010-11-40-1001, 2010-019748-38, NCT01553032
8.	Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced Neuroendocrine Tumors Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CRAD001K24133E1, NCT01595009
9.	I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 to 80 Sponsor: Other Protocol IDs: UKW-NUK-I-124, NCT01704586
10.	Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSOM230B2412, NCT01794793
11.	Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06-2247, NCT00442533
12.	Cisplatin and Radiation Therapy With or Without Gemcitabine Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced Nasopharyngeal Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000657121, SINGAPORE-NCC0901, NCC0901, NCT00997906
13.	Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 2009-02-017, NCT01149161
14.	Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: CSET 1542-JANORL2, 2009-017047-34, NCT01211938
15.	IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients Phase: Phase III, Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: UCL/10/0299, 2011-000144-21, Cancer Research UK, ISRCTN, NCT01398085
16.	Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 9thShanghai, 10DZ1951300, NCT01434394
17.	TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: TPF for resectable OSCC, 2007BAI18B03, NCT01542931
18.	Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UMCNONCO201007, NCT01598402
19.	Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 20111220, NCT01689558
20.	Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: RTOG 1216, NCI-2013-00500, U10CA021661, NCT01810913
21.	Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Active Age: 75 and under Sponsor: Other Protocol IDs: CNR-9506, EU-95024, NCT00002702
22.	A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma Phase: Phase III Type: Treatment Status: Active Age: Under 70 Sponsor: Other Protocol IDs: T1303, NCT00201396
23.	Elective Versus Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: TMH/131/2003, NCT00193765
24.	Oral Cancer Adjuvant Therapy (OCAT) Trial Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: TMH/177/2004, NCT00193843
25.	Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: TROG 05.01, NCT00193895